Pharmaceutical policies: effects of restrictions on reimbursement
نویسندگان
چکیده
منابع مشابه
Pharmaceutical pricing and reimbursement policies: perspectives for the future
Setting the scene For many years, the global approach to pharmaceutical pricing and reimbursement policies has been informed, first and foremost, by the key differences between those systems which relied on public sector procurement and supply, and those which were based on reimbursement. The first approach was considered to be the most appropriate for developing countries. Funding for healthca...
متن کاملChallenges and opportunities for pharmaceutical pricing and reimbursement policies
Even though access to affordable medicines is a human right, it is not ensured world-wide. The Priority Medicines Report 2013 [1] identified pharmaceutical gaps that continue to remain: diseases of public health importance for which pharmaceutical treatments either do not exist or are inadequate (see also K4). Where adequate treatments were available, access might be limited due to high costs o...
متن کاملA framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
Results We developed an analytical framework with which to explore the link between reimbursement and investment in research and development (R&D) yielding incremental, substantial, and radical innovations, as well as in novel products that do not offer new therapeutic advantages over existing treatments. This framework posits that there are three ways that reimbursement policies and practices ...
متن کاملReimbursement restrictions in home health.
ous and constructive disagreement can lead to needed changes. As advocates of rehabilitation for the aging, we need a clear understanding of all reimbursement systems, including the Medicare program, so that we can work effectively within the existing structure, as the letter writers suggest. Even more so, we need the clarity of vision to see where changes in the system are needed, the courage ...
متن کاملAdapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
Problem statement Very high-priced pharmaceuticals also known as “specialty” drugs constitute a large and growing share of total spending on health care in OECD countries. Due to the lack of therapeutic alternatives and high perceived therapeutic value of the drugs, policies used to manage pharmaceutical spending are often impractical or ineffective in the case of specialty drugs. In this envir...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2010
ISSN: 1465-1858
DOI: 10.1002/14651858.cd008654